Clinical Trials on Dysthyroid Orbitopathy

Total 24 results

Silkiss, Rona Z., M.D., FACS
Lauer, Simeon, M.D.; Reier, Alice M.D.; Coleman, Morton M.D.

Completed

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Thyroid Related Orbitopathy | Graves' Dysthyroid Ophthalmopathy

United States
University of Sao Paulo

Completed

Morphometric Analysis of Orbital Structures in Graves´ Orbitopathy

Dysthyroid Orbitopathy

Brazil
Medical University of Warsaw

Completed

Liver Function After Intravenous Methylprednisolone Administration

Liver Diseases | Liver Failure | Graves Ophthalmopathy | Graves Disease | Acute Liver Failure | Acute Liver Injury | Liver Dysfunction | Glucocorticoids Toxicity | Liver Injury | Liver Insufficiency | Acute Liver Injury, Drug Induced | Methylprednisolone Adverse Reaction | Dysthyroid Orbitopathy | Dysthyroid Ophthalmopathy
Fondation Ophtalmologique Adolphe de Rothschild

Completed

mDixon TSE MRI Sequence And Conventional MRI Sequences In Dysimmune Orbitopathies (DDX) (DDX)

Dysthyroid Ophthalmopathies

France
Sheba Medical Center

Unknown

Pascal Pascal Dynamic Contour Tonometer (DCT) Intraocular Pressure and Ocular Pulse Amplitude in Patients With Thyroid Related Orbitopathy: A Comparison to Goldmann Tonometer and to Muscles Characteristics on CT Scan

Thyroid Related Orbitopathy

Israel
Medical University of Silesia

Recruiting

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Graves Orbitopathy

Poland
University Hospital, Montpellier

Completed

Immunological Follow-up of Patients With Basedow's Orbitopathy (SIPO)

Graves Orbitopathy

France
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Not yet recruiting

Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients

Active Moderate to Severe Graves' Orbitopathy
University of Pisa

Recruiting

A Conservative vs an Ablative Approach for Treatment of Hyperthyroidism in Patients With Graves' Orbitopathy (ABLAGO)

Graves' Orbitopathy

Italy
Cairo University

Completed

Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections (TOMATO)

Thyroid Associated Orbitopathy

Egypt
Hospital Universitario 12 de Octubre
The Queen Elizabeth Hospital; Hospital del Río Hortega

Completed

Deep Lateral Wall Partial Rim-Sparing Orbital Decompression for Treatment of Thyroid-Related Orbitopathy

Exophthalmos | Surgery | Orbitopathy, Graves
HaEmek Medical Center, Israel

Unknown

Local Triamcinolone Injection in Active Thyroid Orbitopathy

Thyroid Disease
University of Pisa
University of Messina; University of Catania; Università degli Studi dell'Insubria

Not yet recruiting

A Randomized Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study (STAGO-2)

Graves' Orbitopathy

Italy
Instituto de Oftalmología Fundación Conde de Valenciana

Completed

Oral Supplementation With Selenium in Patients With Mild Thyroid Orbitopathy

Thyroid Orbitopathy
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...
Universität Duisburg-Essen; Cultech Ltd, Port Talbot, UK; School of Medicine... and other collaborators

Unknown

Role of the Microbiome in Graves' Orbitopathy (Indigo)

Graves' Disease

Italy
Lund University

Recruiting

Treatment of Graves´Ophthalmopathy With Simvastatin (GO-S)

Graves Ophthalmopathy | Thyroid Associated Ophthalmopathy | Thyroid Associated Orbitopathy

Sweden
Horizon Pharma USA, Inc.

Completed

Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC)

Thyroid Eye Disease | Graves' Orbitopathy

United States, Italy, Germany
Horizon Pharma USA, Inc.

Approved for marketing

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease (EAP)

Thyroid Eye Disease | Graves' Orbitopathy

United States
Novartis Pharmaceuticals

Terminated

A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED) (ORBIT)

Thyroid Eye Disease | Graves Orbitopathy

Germany
University of Pisa

Completed

Disappearance of Graves' Orbitopathy (DISGO)

Thyroid Eye Disease
Lassen Therapeutics Inc.

Recruiting

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Eye Diseases | Endocrine System Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis

United States, United Kingdom, Spain
Medical University of Warsaw

Recruiting

Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease)

Thyroid Eye Disease | Ophthalmopathy | Orbitopathy, Graves

Poland
Sling Therapeutics, Inc.

Recruiting

A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States
Sling Therapeutics, Inc.

Recruiting

A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (LIDS)

Eye Diseases | Endocrine System Diseases | Thyroid Diseases | Thyroid Eye Disease | Graves Ophthalmopathy | Exophthalmos | Orbital Diseases | Thyroid Associated Ophthalmopathy | Graves Orbitopathy | Proptosis | IGF1R | Hashimoto

United States, Spain, Canada, Italy, United Kingdom

Clinical Trials on Dysthyroid Orbitopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations